0 results found with selected filters. Please refine the filters. Redirecting to initial search..
How to display a graph
Please select the measurements of same unit in the left filter pane to view the graph.
downloaded on: 2024/10/05 05:15:17
Strain |
Phenotype |
Conditions |
Study |
Experiment Name |
Sex |
Age |
# of Animals |
Value |
Units |
SEM |
SD |
Method |
Method Duration |
Post Insult Type |
Post Insult Time Value |
Post Insult Time Unit |
Method Notes |
Clinical Measurement Notes |
Record ID |
Study ID |
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
mammary tumor number |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
186 days-191 days |
46 |
7.61 |
null |
0.07 |
0.45 |
necropsy |
0 |
DMBA oral gavage |
0 |
|
necropsy |
|
11342 |
73 |
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
post-insult time to mammary tumor formation |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
99 days-104 days |
46 |
45.91 |
d |
0.19 |
1.27 |
manual palpation method |
0 |
DMBA oral gavage |
0 |
|
|
|
11345 |
73 |
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
mammary tumor growth rate |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) |
Piessevaux G, et al., Mamm Genome. 2008 Dec 4 |
mammary gland integrity trait |
female |
0 days
| 52 |
0.73 |
cm/week |
0.03 |
0.22 |
unspecified method |
0 |
DMBA oral gavage |
0 |
|
|
the first 3 weeks of tumor growth |
11511 |
74 |
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
mammary tumor number |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) |
Piessevaux G, et al., Mamm Genome. 2008 Dec 4 |
mammary gland integrity trait |
female |
0 days
| 46 |
7.61 |
null |
0.45 |
3.05 |
manual palpation method |
0 |
DMBA oral gavage |
133 |
days |
|
|
11356 |
74 |
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
mammary tumor growth rate |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) |
Stieber D, et al., Int J Cancer. 2007 Jan 17 |
mammary gland integrity trait |
female |
99 days-120 days |
46 |
0.79 |
cm/week |
0.01 |
0.05 |
unspecified method |
0.0 |
DMBA oral gavage |
0 |
|
|
the first 3 weeks of tumor growth |
11348 |
73 |
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
mammary gland terminal end bud count |
control condition |
Lella V, et al., Int J Cancer. 2007 Oct 15;121(8):1738-43. |
mammary gland development trait |
female |
55 days
| 5 |
60.3 |
null |
4.9 |
10.96 |
ex vivo light microscopy |
0 |
|
0 |
|
|
|
66137 |
709 |
|